China Pharma Holdings (CPHI) Reports Q1 Loss of $0.04/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
China Pharma Holdings, Inc. Reports First Quarter Financial Results
May 17, 2016 6:01 AM EDTHAIKOU CITY, China, May 17, 2016 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China, today announced financial results for the quarter ended March 31, 2016.
First Quarter Highlights
Revenue was $3.6 million in first quarter 2016, which represented a decrease of 36.1% compared to $5.7 million in the same period 2015; Gross margin was 17.6% in first quarter 2016, compared to 18.6% in the same period 2015; Net loss was $1.6 million in... More